Skip to content
Breathing, swallowing or vision problems: call the emergency services (15 or 112 in France).

Chin problems after Botox: stiff chin, what to do

After a botulinum toxin injection in the chin, often to soften a dimpled appearance, the chin may look stiff and the movement of the lips may change. These effects are temporary, and the practice is off-label in France. This page presents the possible problems, the warning signs and a page for each one.

The chin is moved by a small muscle, the mentalis, which pushes it up and creases the skin when you pout or press your lips together. In some people, its contraction gives the chin a dimpled, "orange peel" appearance7. This page is part of our SOS guide for problems after an injection, organised area by area.

What problems can affect the chin?

Chin problems

The situation presented in the atlas is the stiff chin: a chin that no longer moves as before, sometimes with difficulty moving the lower lip. The second situation is a chin that is still dimpled, or has become bumpy, after the injection: part of the muscle relaxed incompletely or unevenly can form a paradoxical bulge, described by an expert consensus6 and in a published case, where it appeared the day after the injection7. It is covered in the page on a dimpled or bumpy chin after an injection.

This needs saying clearly: problems after a chin injection are poorly documented. The dimpled chin is among the areas covered by an expert consensus published in 20041, but the official labels do not describe this injection, since it is not an approved indication, and we have not found a reliable source giving figures for its adverse effects. What is known in general applies: the effect of the toxin is temporary and wears off as the nerve terminals recover3.

Which signs mean you should see a doctor quickly?

A chin that is a little stiff is bothersome but not dangerous. See a doctor promptly if you have trouble keeping liquids in your mouth, eating or speaking clearly, or if the lower lip droops noticeably. Warm, painful redness spreading from an injection point may be a sign of local infection, which is among the possible reactions3.

Any difficulty swallowing, speaking or breathing means calling emergency services (15 or 112 in France, or your local emergency number): the labels describe these as the rare signs of the toxin spreading away from the injection site, which require immediate medical care2,3.

Before seeing a doctor, write down the date of the injection and the day the problem appeared. If possible, contact the doctor who performed the injection: they know which points were treated and with which product.

Why is the chin injected?

Chin injections aim to soften the dimpled appearance of the skin, the "dimpled chin" described by the 2004 expert consensus1. No French label provides for this indication: type A toxins have aesthetic indications limited to frown lines, crow’s feet and forehead lines, depending on the product2, and the short-acting botulinum toxin (serotype E) to frown lines only3, approved as of 9 October 2026 in the European Union and Canada4,5. It is therefore an off-label use, to be discussed with your doctor. To understand why and how the chin can be treated, see the page for this area in our atlas of treatment areas.

The chin sits next to the lips and the jaw: if your problem mainly affects the mouth, see the page on lips after an injection; if it concerns chewing or the angle of the jaw, the page on the jaw after masseter injections.

Key points

  • Two problems presented: the stiff chin, sometimes with difficulty moving the lower lip, and a chin that stays dimpled or becomes bumpy6,7.
  • Treating the chin is an off-label use in France2,3.
  • Adverse effects specific to the chin are poorly documented; they remain temporary3.
  • Difficulty drinking, eating or speaking: see a doctor; difficulty swallowing or breathing: call emergency services.

Frequently asked questions

  • Is botulinum toxin approved for the chin?

    No, not for aesthetic use in France. The French labels of type A toxins limit their aesthetic indications to frown lines, crow’s feet and forehead lines, depending on the product2, and the short-acting toxin is approved only for frown lines3. The dimpled chin is among the areas covered by an expert consensus published in 20041, but treating it remains an off-label use, to be discussed with your doctor.

Sources

  1. 1.Carruthers J. et al., expert consensus on botulinum toxin in facial aesthetics, Plastic and Reconstructive Surgery, 2004 (opens in a new tab) — Plastic and Reconstructive Surgery
  2. 2.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
  3. 3.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
  4. 4.European public assessment report (EPAR) of the serotype E botulinum toxin (opens in a new tab) — European Commission (Union Register of medicinal products)
  5. 5.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada
  6. 6.Fundarò S. et al., Italian consensus and review on treating the lower face muscles with type A botulinum toxin, Toxins, 2026 (opens in a new tab) — Toxins (MDPI)
  7. 7.Yu N. et al., paradoxical bulging of the mentalis muscle after type A botulinum toxin injection: case report, Journal of Cosmetic Dermatology, 2020 (opens in a new tab) — Journal of Cosmetic Dermatology
Book an appointmentSOS after an injection